Trial Profile
A Double-Blind, Randomized, Multi-Center Study Followed By 12 Months Open-Label Treatment To Evaluate The Dose Response And Safety Of Valsartan In Pediatric Hypertension Patients 1 – 5 Years Of Age.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Nov 2011
Price :
$35
*
At a glance
- Drugs Valsartan (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- 07 Nov 2011 Actual end date (November 2006) added as reported by ClinicalTrials.gov.
- 01 Aug 2008 Results published in Hypertension.
- 30 Oct 2005 New trial record.